Description
The BRCA2 c.5319G>A variant was identified in dbSNP (ID: rs376257217) as “With Likely benign allele”, Clinvitae database (likely benign by ClinVar and Invitae), the ClinVar database (likely benign by Ambry Genetics and Invitae), UMD (5x with an “unclassified variant” classification). This variant was also identified in the NHLBI GO Exome Sequencing Project in 1 of 4402 African American alleles, the Exome Aggregation Consortium database (August 8, 2016) in 2 of 120574 chromosomes (freq. 0.00002) in the following populations: African in 1 of 10222 chromosomes (freq. 0.0001), European in 1 of 66222 chromosomes (freq. 0.00002), increasing the likelihood that this may be a low frequency benign variant in certain populations of origin. The c.5319G>A variant is not expected to have clinical significance because it does not result in a change of amino acid (p.Glu1773Glu) and is not located in a known consensus splice site. The variant occurs outside of the splicing consensus sequence and 2 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict a greater than 10% difference in splicing: this is not very predictive of pathogenicity. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign.
# | Sample | Method | Observation |
---|
Origin | Affected | Number tested | Tissue | Purpose | Method | Individuals | Allele frequency | Families | Co-occurrences |
---|
1 | unknown | yes | not provided | not provided | not provided | | 1 | not provided | not provided | not provided |